Authors


Joan Lockhart, PhD

Latest:

Joan Lockhart on Follow-Up Care for Patients With Head and Neck Cancer

​Joan Lockhart, PhD, RN, CORLN, AOCN, CNE, ANEF, FAAN, clinical professor at Duquesne University School of Nursing, discusses issues oncology nurses should monitor for when treating patients with head and neck cancer.


Kathleen A. Gamblin, RN, BSN, OCN

Latest:

Building Trust and Giving Voice to the Patient's Wishes

Linda told me the too often heard story of a routine chest x-ray before surgery, and suddenly, the anxiety over having a gallbladder removed was overshadowed by the news that the x-ray revealed a large lung mass.


Debi Fischer, MSW, BSN, BA, LCSW, RN

Latest:

Revisiting My Interview With Suzanne Somers

Suzanne Somers had her critics, but many applauded her approach to health care and cancer.


Robert Dreicer, MD

Latest:

Predicting Immunotherapy Response in Bladder Cancer

PD-L1 status may not be the best predictor when it comes to determining who will respond to checkpoint blockade.


Conor Killmurray

Latest:

Mirvetuximab Soravtansine Bests Chemo in HRQOL for FRα+ Ovarian Cancer

Further evidence strengthens the support of mirvetuximab soravtansine as a new standard of care for folate receptor-alpha—positive ovarian cancer resistant to platinum chemotherapy.


Elena Ratner, MD

Latest:

Elena Ratner on Menopause and Breast Cancer Treatments

Dr. Elena Ratner discusses the interaction between menopause and certain treatments for breast cancer.


Kristie Kahl

Latest:

Adding Nivolumab to Chemotherapy Improves Survival Rates in Metastatic Urothelial Carcinoma

Nivolumab plus gemcitabine-cisplatin improved overall and progression-free survival in unresectable or metastatic urothelial carcinoma.


Pamela Devine, RN

Latest:

Pamela Devine Discusses Psychosocial Issues Concerning Men with Prostate Cancer

Pamela Devine, RN, clinical nurse specialist, Philadelphia Veterans Administration Medical Center, discusses some of the psychosocial issues that men face when they are receiving treatment for their prostate cancer.


Ellen T. Matloff, MS, CGC, President

Latest:

What to Do When a Patient Brings in Direct-to-Consumer Genetic Test Results for Your Review

A guide for oncology nurses on navigating the ever-growing field of direct-to-consumer genetic testing.


Janet A. Deatrick, PhD, FAAN, Elizabeth G. Broden, BSN

Latest:

Helping Caregivers and Families Feel More Able to Manage

Caregivers of young adult survivors (YAS) of childhood brain tumors, usually their mothers, live dramatically altered lives as they incorporate illness management into family life and function in caregiving roles well into the survivors’ adulthood.


Anita T. Shaffer

Latest:

Frontline Treatment of Metastatic NSCLC Depends on Biomarkers and Histology

Choosing frontline therapy for patients with metastatic non–small cell lung cancer (NSCLC) who do not harbor an actionable driver oncogene depends upon PD-L1 expression level and histology, according to Gregory J. Riely, MD, PhD.


Jae Park, MD

Latest:

Jae Park on Clinical Trials for CAR T-Cell Activation Therapy

Jae Park, MD, hematologist-oncologist, Memorial Sloan Kettering Cancer Center, talks about CAR T-cell activation therapy, which is currently in clinical trials for patients with acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), and non-Hodgkin lymphoma.


Olga Ivanov, MD

Latest:

Olga Ivanov Discusses Sexual Health After Risk-Reducing Cancer Surgery

Olga Ivanov, MD, breast cancer surgeon at the Florida Hospital Cancer Institute, discusses sexual difficulties women who have had risk-reducing cancer surgery face.


Kim Christen, RN, BSN, OCN

Latest:

Kim Christen on Creating a Patient-Driven Protocol for the Specialty Pharmacy

Kim Christen, RN, BSN, OCN, of Kootenai Clinic Cancer Services discusses the process of creating a protocol for the onsite pharmacy at Kootenai that keeps patients at the center.


Lisa Miller

Latest:

Using Antibiotics Could Affect Checkpoint Inhibitors

A recent study presented at the 2017 Genitourinary Cancers Symposium found that use of antibiotics could damper the efficacy of checkpoint inhibitors, potentially due to the relationship between gut microbiota and antibiotics.


Melissa B. Davis, PhD

Latest:

Do Targeted Therapies Drive Disparities?

After the widespread use of targeted therapies for breast cancer treatment, there was a wider gap in mortality rates between black and white women with the disease.




Erin Murphy-Wilczek, LSW

Latest:

Mindfulness Can Help Patients With Cancer

Mindfulness can be a powerful tool to reduce stress and improve patients' outlook after being diagnosed with cancer.


Patricia Kropf, MD

Latest:

Patricia Kropf on Home Administration of Synribo for CML

Patricia Kropf, MD, assistant professor, Division of Bone Marrow Transplants, Fox Chase Cancer Center, discusses home administration of Synribo (omacetaxine mepesuccinate).


Kathryn Ciccolini, RN, BSN, OCN, DNC

Latest:

Kathryn Ciccolini on the Increase of Dermatologic AE's With New Cancer Therapies

Kathryn Ciccolini, RN, BSN, OCN, DNC, Memorial Sloan Kettering Cancer Center, discusses the increase of dermatologic adverse events with new cancer therapies.


Carolyn Phillips, MSN, RN, ACNP-BC, AOCNP

Latest:

Carolyn Phillips on Songwriting as Emotional Healing for Nurses

​Carolyn Phillips, MSN, RN, ACNP-BC, AOCNP, University of Texas at Austin, School of Nursing, discusses her program for nurses, Songs for the Soul


Miguel-Angel Perales, MD

Latest:

Miguel-Angel Perales on Graft Versus Host Disease

Miguel-Angel Perales, MD, deputy chief, Adult Bone Marrow Transplant Service, director, Adult Bone Marrow Transplantation Fellowship Program, Memorial Sloan Kettering Cancer Center, discusses graft versus host disease (GVHD) after a bone marrow transplant.


Deborah A. Boyle, MSN, RN, AOCNS, FAAN

Latest:

Vaping Presents an Old Danger to a New Generation

Tobacco use among young people is an old problem that now challenges a new generation in a new form: vaping.


Taofeek Owonikoko, MD, PhD, MSCR

Latest:

Avoiding Needless Testing in NSCLC Treatment

With the emphasis on testing for biomarkers to determine treatment for patients with lung cancer, it's important to make sure the testing will have an impact on clinical decisions.


David Leos, RN, MBA, OCN

Latest:

Understanding Breast Implant-Associated Anaplastic Large Cell Lymphoma

A form of T-cell (non-Hodgkin) lymphoma known as breast implant associated anaplastic large-cell lymphoma (BIA-ALCL) has been noted as a rare association with the implant-based approach of reconstructive surgery post mastectomy.


Bonnie Gillis

Latest:

Partial Breast Irradiation as Effective as Conventional Therapy

Accelerated partial breast irradiation (APBI) using multicatheter brachytherapy in patients with early-stage breast cancer was not inferior to conventional whole breast irradiation (WBI), according to a phase III study presented at the 2015 American Society for Radiation Oncology (ASTRO) Annual Meeting.


Danielle Novetsky Friedman

Latest:

Danielle Novetsky Friedman on Abdominal Radiation and Diabetes Risk

Danielle Novetsky Friedman, a general pediatrician in the Pediatric Long-Term Follow-Up Program at Memorial Sloan Kettering Cancer Center (MSK), discusses a study investigating the mechanisms leading to abnormal glucose and insulin dynamics in survivors of childhood cancers.


Helen Foley, MSN, AOCNS®

Latest:

Preparing Nurses for Advanced Practice in Oncology and Palliative Care

Barbara Daly, PhD, RN, FAAN, and Helen Foley, MSN, AOCNS®, offer highlights of their institution's oncology and palliative care program, which successfully prepares graduates to assume advanced practice roles in these important areas.


Annie Lattanzio Hale RN, BSN, OCN

Latest:

Finding Our Way by Helping Patients Along Their Way

I am used to it now, the chuckles and candid references to compasses and aviation from some and the grateful looks from others, as though I have just extended them a lifeline.

© 2024 MJH Life Sciences

All rights reserved.